GSK bets on pioneering cancer therapy with Adaptimmune deal Ruby Khatun Khatun9 Sept 2017 9:32 AM ISTLONDON: GlaxoSmithKline (GSK) said it has licensed the rights to Adaptimmune's pioneering T-cell therapy program to boost its pipeline in oncology,...
Eisai signs agreement with Merck to expand enrollment of combination study for Lenvima and Pembrolizumab Ruby Khatun Khatun8 Sept 2017 1:28 PM ISTTOKYO: Eisai Co., Ltd. has announced that it has signed an agreement with Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside of the...
Indias loss is over Rs 60 lakh crore each year due to poor healthcare: Vazirani Ruby Khatun Khatun8 Sept 2017 1:28 PM ISTMumbai: The 10th Medtech Conference of Confederation of Indian Industries (CII) witnessed the coming together of officials from the Central and State...
Technology can help reduce healthcare costs: Health Minister Ruby Khatun Khatun8 Sept 2017 1:24 PM ISTNew Delhi: The government is committed to technology integration in the health sector, Minister of State for Health Anupriya Patel said on Thursday,...
Cipla promoters, relatives get into share transfer agreement Ruby Khatun Khatun8 Sept 2017 1:21 PM ISTNew Delhi: Drug firm Cipla said some of its promoters and promoter group along with their relatives have entered into an agreement on the transfer of...
Dr Reddys launches antidepressant, muscle relaxant tablets in US Ruby Khatun Khatun7 Sept 2017 11:19 AM ISTNew Delhi: Dr. Reddy's Laboratories on Wednesday said it has launched Bupropion Hydrochloride extended-release tablets used in treating a major...
Novo Nordisk settles US probe over diabetes drug for nearly 58.7 million dollar Ruby Khatun Khatun7 Sept 2017 10:48 AM ISTNovo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker's sales staff downplayed the importance of U.S. Food and Drug...
Device maker Teleflex boosts urology business with NeoTract buy Ruby Khatun Khatun7 Sept 2017 10:17 AM ISTMedical device maker Teleflex Inc said on Tuesday it would buy privately held NeoTract Inc in its second billion-dollar deal in the past nine months,...
US judge invalidates Mallinckrodt patents on respiratory treatment Ruby Khatun Khatun7 Sept 2017 9:47 AM ISTA federal judge in Delaware on Tuesday invalidated patents held by Mallinckrodt Pharmaceuticals on its Inomax respiratory treatment system.The ruling...
Ajanta Pharma gets USFDA nod for Parkinsons disease tablet Ruby Khatun Khatun6 Sept 2017 11:08 AM ISTNew Delhi: Ajanta Pharma has received final approval from the US health regulator for Entacapone tablets, used in the treatment of Parkinson's...
Four executives to leave Reckitt Benckiser amid company struggles Ruby Khatun Khatun6 Sept 2017 10:47 AM ISTLONDON: Four senior executives are leaving Reckitt Benckiser Group as the British consumer goods company fights to recover from the weakest...
Roche lung cancer drug Alecensa slashes brain risk in tests Ruby Khatun Khatun6 Sept 2017 10:17 AM ISTPatients taking Roche’s targeted lung cancer drug Alecensa have a far lower risk of their disease spreading in the brain than those on Pfizer’s...
